FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

703796003: Ponatinib (substance)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2014. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3009418013 Ponatinib en Synonym Active Entire term case insensitive SNOMED CT core module
3009711015 Ponatinib (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ponatinib Is a Substance with protein-tyrosine kinase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Ponatinib Has disposition Protein-tyrosine kinase inhibitor true Inferred relationship Existential restriction modifier
Ponatinib Is a Chemical categorized functionally false Inferred relationship Existential restriction modifier
Ponatinib Is a Substance with enzyme inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Ponatinib Is a Benzamide false Inferred relationship Existential restriction modifier
Ponatinib Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Ponatinib Is a Substance with benzamide structure true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Ponatinib hydrochloride Is a False Ponatinib Inferred relationship Existential restriction modifier
Product containing ponatinib Has active ingredient True Ponatinib Inferred relationship Existential restriction modifier 1
Product containing precisely ponatinib (as ponatinib hydrochloride) 15 milligram/1 each conventional release oral tablet Has basis of strength substance True Ponatinib Inferred relationship Existential restriction modifier 1
Product containing precisely ponatinib (as ponatinib hydrochloride) 45 milligram/1 each conventional release oral tablet Has basis of strength substance True Ponatinib Inferred relationship Existential restriction modifier 1
Product containing ponatinib in oral dose form (medicinal product form) Has active ingredient True Ponatinib Inferred relationship Existential restriction modifier 1
Ponatinib hydrochloride Is modification of True Ponatinib Inferred relationship Existential restriction modifier
Ponatinib Has active ingredient True Ponatinib Inferred relationship Existential restriction modifier 1
Product containing only ponatinib in oral dose form (medicinal product form) Has active ingredient True Ponatinib Inferred relationship Existential restriction modifier 1
Product containing precisely ponatinib (as ponatinib hydrochloride) 30 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Ponatinib Inferred relationship Existential restriction modifier 1
Product containing precisely ponatinib (as ponatinib hydrochloride) 45 milligram/1 each conventional release oral tablet Has active ingredient False Ponatinib Inferred relationship Existential restriction modifier
Iclusig 15mg tablets (Incyte Biosciences UK Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Ponatinib Inferred relationship Existential restriction modifier
Ponatinib 15mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Ponatinib Inferred relationship Existential restriction modifier
Product containing precisely ponatinib (as ponatinib hydrochloride) 15 milligram/1 each conventional release oral tablet Has active ingredient False Ponatinib Inferred relationship Existential restriction modifier
Ponatinib 15mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Ponatinib Inferred relationship Existential restriction modifier
Ponatinib 45mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance False Ponatinib Inferred relationship Existential restriction modifier
Ponatinib 15mg tablets 60 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Ponatinib Inferred relationship Existential restriction modifier
Iclusig 15mg tablets (Ariad Pharma (UK) Ltd) 60 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Ponatinib Inferred relationship Existential restriction modifier
Iclusig 45mg tablets (Ariad Pharma (UK) Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Ponatinib Inferred relationship Existential restriction modifier
Iclusig 15mg tablets (Ariad Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Ponatinib Inferred relationship Existential restriction modifier
Iclusig 45mg tablets (Ariad Pharma (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Ponatinib Inferred relationship Existential restriction modifier
Ponatinib 45mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Ponatinib Inferred relationship Existential restriction modifier
Ponatinib 15mg tablets Has active ingredient False Ponatinib Inferred relationship Existential restriction modifier
Ponatinib 45mg tablets Has active ingredient False Ponatinib Inferred relationship Existential restriction modifier
Iclusig 15mg tablets (Ariad Pharma (UK) Ltd) Has active ingredient False Ponatinib Inferred relationship Existential restriction modifier
Iclusig 45mg tablets (Ariad Pharma (UK) Ltd) Has active ingredient False Ponatinib Inferred relationship Existential restriction modifier
Product containing precisely ponatinib (as ponatinib hydrochloride) 45 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Ponatinib Inferred relationship Existential restriction modifier
Product containing precisely ponatinib (as ponatinib hydrochloride) 15 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Ponatinib Inferred relationship Existential restriction modifier
Ponatinib 15mg tablets 60 tablet Has basis of strength substance True Ponatinib Inferred relationship Existential restriction modifier
Iclusig 15mg tablets (Ariad Pharma (UK) Ltd) 60 tablet Has basis of strength substance True Ponatinib Inferred relationship Existential restriction modifier
Iclusig 45mg tablets (Ariad Pharma (UK) Ltd) 30 tablet Has basis of strength substance True Ponatinib Inferred relationship Existential restriction modifier
Iclusig 15mg tablets (Ariad Pharma (UK) Ltd) Has basis of strength substance True Ponatinib Inferred relationship Existential restriction modifier
Iclusig 45mg tablets (Ariad Pharma (UK) Ltd) Has basis of strength substance True Ponatinib Inferred relationship Existential restriction modifier
Ponatinib 45mg tablets 30 tablet Has basis of strength substance True Ponatinib Inferred relationship Existential restriction modifier
Product containing precisely ponatinib (as ponatinib hydrochloride) 45 milligram/1 each conventional release oral tablet Has basis of strength substance False Ponatinib Inferred relationship Existential restriction modifier
Product containing precisely ponatinib (as ponatinib hydrochloride) 15 milligram/1 each conventional release oral tablet Has basis of strength substance False Ponatinib Inferred relationship Existential restriction modifier
Ponatinib 30mg tablets Has active ingredient False Ponatinib Inferred relationship Existential restriction modifier
Ponatinib 30mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Ponatinib Inferred relationship Existential restriction modifier
Iclusig 30mg tablets (Incyte Biosciences UK Ltd) Has active ingredient True Ponatinib Inferred relationship Existential restriction modifier
Iclusig 30mg tablets (Incyte Biosciences UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Ponatinib Inferred relationship Existential restriction modifier
Ponatinib 30mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Ponatinib Inferred relationship Existential restriction modifier
Ponatinib 15mg tablets 30 tablet Has basis of strength substance True Ponatinib Inferred relationship Existential restriction modifier
Iclusig 15mg tablets (Incyte Biosciences UK Ltd) 30 tablet Has basis of strength substance True Ponatinib Inferred relationship Existential restriction modifier
Iclusig 30mg tablets (Incyte Biosciences UK Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Ponatinib Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start